These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 21396667)

  • 1. [Risk of pneumonia with inhaled corticosteroids for stable chronic obstructive pulmonary disease patients].
    Ruiz García V; Compte Torrero L
    Med Clin (Barc); 2011 Sep; 137(7):302-4. PubMed ID: 21396667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of inhaled corticosteroids in chronic obstructive pulmonary disease (COPD).
    Med Lett Drugs Ther; 2010 May; 52(1339):41-2. PubMed ID: 20508579
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of inhaled corticosteroids /long-acting agonists in a single inhaler versus inhaled corticosteroids alone on all-cause mortality, pneumonia, and fracture in chronic obstructive pulmonary disease: A nationwide cohort study 2002-2013.
    Cho KH; Kim YS; Linton JA; Nam CM; Choi Y; Park EC
    Respir Med; 2017 Sep; 130():75-84. PubMed ID: 29206637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Risk of pneumonia in patients with chronic obstructive pulmonary disease treated with inhaled corticosteroids: evidence and uncertainties].
    Incorvaia C; Gritti B; Martignago I; Riario-Sforza GG; Ridolo E
    Ig Sanita Pubbl; 2016; 72(6):583-588. PubMed ID: 28214911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Role of inhaled corticosteroids in the management of COPD].
    Chazan R
    Pneumonol Alergol Pol; 2009; 77(2):186-91. PubMed ID: 19462354
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined inhaled corticosteroid and long-acting beta-2-agonist in one inhaler in the treatment of chronic obstructive pulmonary disease].
    Pedersen ST
    Ugeskr Laeger; 2005 Jun; 167(23):2504-6. PubMed ID: 16008004
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of long acting β₂-agonists, alone or in combination with inhaled corticosteroids, in chronic obstructive pulmonary disease (COPD): a risk-benefit analysis.
    Cave AC; Hurst MM
    Pharmacol Ther; 2011 May; 130(2):114-43. PubMed ID: 21276815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis.
    Singh S; Amin AV; Loke YK
    Arch Intern Med; 2009 Feb; 169(3):219-29. PubMed ID: 19204211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled corticosteroids and risk of pneumonia in patients with chronic obstructive pulmonary disease: A meta-analysis of randomized controlled trials.
    Yang M; Du Y; Chen H; Jiang D; Xu Z
    Int Immunopharmacol; 2019 Dec; 77():105950. PubMed ID: 31629940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incident pneumonia and mortality in patients with chronic obstructive pulmonary disease. A double effect of inhaled corticosteroids?
    Festic E; Scanlon PD
    Am J Respir Crit Care Med; 2015 Jan; 191(2):141-8. PubMed ID: 25409118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pneumology. Inhaled corticosteroids in COPD: more and interesting data!].
    Rochat T
    Rev Med Suisse; 2008 Jan; 4(140):155-7. PubMed ID: 18309880
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled corticosteroids in chronic obstructive pulmonary disease: is there a clinical benefit?
    Man SF; Sin DD
    Drugs; 2005; 65(5):579-91. PubMed ID: 15748094
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
    Baker WL; Baker EL; Coleman CI
    Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination long-acting β-agonists and inhaled corticosteroids compared with long-acting β-agonists alone in older adults with chronic obstructive pulmonary disease.
    Gershon AS; Campitelli MA; Croxford R; Stanbrook MB; To T; Upshur R; Stephenson AL; Stukel TA
    JAMA; 2014 Sep; 312(11):1114-21. PubMed ID: 25226477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scientific rationale for the possible inhaled corticosteroid intraclass difference in the risk of pneumonia in COPD.
    Janson C; Stratelis G; Miller-Larsson A; Harrison TW; Larsson K
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3055-3064. PubMed ID: 29089754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the benefits and drawbacks of inhaled corticosteroids in chronic obstructive pulmonary disease.
    Singh S; Loke YK
    Int J Chron Obstruct Pulmon Dis; 2010 Aug; 5():189-95. PubMed ID: 20714372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis.
    Pavord ID; Lettis S; Anzueto A; Barnes N
    Lancet Respir Med; 2016 Sep; 4(9):731-741. PubMed ID: 27460163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single inhaler budesonide/formoterol in exacerbations of chronic obstructive pulmonary disease.
    Cazzola M
    Pulm Pharmacol Ther; 2006; 19(2):79-89. PubMed ID: 15964228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhaled corticosteroids and pneumonia in chronic obstructive pulmonary disease.
    Finney L; Berry M; Singanayagam A; Elkin SL; Johnston SL; Mallia P
    Lancet Respir Med; 2014 Nov; 2(11):919-932. PubMed ID: 25240963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.